Effect of plasmapheresis on ATG (Thymoglobulin) clearance prior to adoptive T cell transfer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of plasmapheresis on ATG (Thymoglobulin) clearance prior to adoptive T cell transfer

Published:2019-03-19 Issue:12 Volume:54 Page:2110-2116
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Zhang Ping,Curley Cameron I.,Mudie Kari,Nakagaki Midori,Hill Geoffrey R.,Roberts Jason A.,Tey Siok-Keen

Funder

Department of Health, Queensland

Department of Health | National Health and Medical Research Council

QIMR Berghofer Ride To Conquer Cancer Flagship Award and Royal Brisbane and Women’s Hospital Foundation

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-019-0505-5.pdf

Reference23 articles.

1. Bacigalupo A. ATG in allogeneic stem cell transplantation: standard of care in 2017? Point. Blood Adv. 2017;1:569–72. https://doi.org/10.1182/bloodadvances.2016001560

2. Kekre N, Antin JH. ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint. Blood Adv. 2017;1:573–6. https://doi.org/10.1182/bloodadvances.2016001552

3. Kroger N, Solano C, Wolschke C, Bandini G, Patriarca F, Pini M, et al. Antilymphocyte globulin for prevention of chronic graft-versus-host disease. N Engl J Med. 2016;374:43–53. https://doi.org/10.1056/NEJMoa1506002

4. Soiffer RJ, Kim HT, McGuirk J, Horwitz ME, Johnston L, Patnaik MM, et al. Prospective, randomized, double-blind, phase III clinical trial of anti-T-lymphocyte globulin to assess impact on chronic graft-versus-host disease-free survival in patients undergoing HLA-matched unrelated myeloablative hematopoietic cell transplantation. J Clin Oncol. 2017;35:4003–11. https://doi.org/10.1200/jco.2017.75.8177

5. Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol. 2005;23:3447–54. https://doi.org/10.1200/jco.2005.09.117

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients Beyond the Optimal Range of rATG-AUC Still Benefit from the Targeted Dosing Strategy in Unmanipulated Haplo-PBSCT;Transplantation and Cellular Therapy;2024-08

2. Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT;Blood Advances;2024-04-28

3. IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation;Journal of Clinical Investigation;2024-04-01

4. A Case of Posttransplant Recurrence of Focal Segmental Glomerulosclerosis with Donor-derived Immunoglobulin A Nephropathy and Banff IIA Acute Cell-mediated Rejection: A Therapeutic Challenge;Indian Journal of Transplantation;2024-04

5. Optimum timing of antithymocyte globulin in relation to adoptive regulatory T cell therapy;American Journal of Transplantation;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3